OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 1,000 | -99.8% | 0.00% | – |
| Q1 2016 | $311,000 | -65.7% | 552,725 | +4.9% | 0.00% | – |
| Q4 2015 | $907,000 | +87.4% | 527,000 | +129.6% | 0.00% | – |
| Q3 2015 | $484,000 | -77.3% | 229,560 | -46.7% | 0.00% | -100.0% |
| Q2 2015 | $2,132,000 | -5.3% | 430,537 | +49.7% | 0.00% | 0.0% |
| Q1 2015 | $2,252,000 | -56.5% | 287,675 | -66.3% | 0.00% | 0.0% |
| Q4 2014 | $5,178,000 | +3572.3% | 854,431 | +2484.8% | 0.00% | – |
| Q3 2014 | $141,000 | -30.9% | 33,056 | 0.0% | 0.00% | – |
| Q2 2014 | $204,000 | -90.8% | 33,056 | -90.3% | 0.00% | -100.0% |
| Q1 2014 | $2,216,000 | +34.8% | 340,901 | +16.8% | 0.00% | – |
| Q4 2013 | $1,644,000 | -27.6% | 291,936 | -21.2% | 0.00% | -100.0% |
| Q3 2013 | $2,270,000 | -40.6% | 370,270 | -43.3% | 0.00% | 0.0% |
| Q2 2013 | $3,819,000 | – | 653,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |